Summary & Overview
HCPCS P9039: Red Blood Cells, Deglycerolized, Each Unit
HCPCS Level II code P9039 denotes a unit of deglycerolized red blood cells—frozen red blood cells that have been thawed and processed for transfusion. This code matters nationally because deglycerolized units are used for patients requiring rare or long-term stored blood products, impacting hospital blood bank operations, supply chain management, and clinical transfusion workflows.
Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code and its clinical context, payer coverage considerations, and what to expect in claims processing for supply and preparation of frozen-thawed blood units. The publication provides benchmarks where available, summarizes relevant policy elements affecting coverage and reimbursement for transfused deglycerolized red blood cells, and situates the code within blood-bank and transfusion service lines.
The write-up is intended for national audiences including hospital billing staff, blood bank managers, and policy analysts seeking clarity on coding, billing implications, and the clinical role of deglycerolized red blood cell units. Data not included in the input is noted explicitly.
Billing Code Overview
HCPCS Level II code P9039 describes red blood cells, deglycerolized, each unit. This service entails provision of deglycerolized packed red blood cells—blood units that have undergone glycerol removal to enable frozen storage and subsequent thawing and preparation for transfusion. The service type is transfusion blood product supply and preparation. The typical site of service is hospital inpatient and hospital outpatient settings where transfusions and blood bank services are performed, including transfusion centers and surgical suites.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with a history of end-stage liver disease and chronic anemia is admitted to the hospital for progressive symptomatic anemia with hemoglobin 6.8 g/dL, dyspnea on exertion, and orthostasis. The transfusion service evaluates the patient and orders a matched unit of P9039 — red blood cells, deglycerolized, each unit — because the patient previously received frozen, glycerol-cryopreserved autologous or rare-donor red blood cells that require deglycerolization before transfusion. The transfusion laboratory retrieves a frozen unit from long-term storage, performs thawing and controlled deglycerolization to remove cryoprotectant, performs standard infectious disease testing and crossmatch or antibody compatibility testing, and releases the unit. Nursing obtains informed consent, confirms patient identifiers and transfusion orders, and administers the deglycerolized red blood cell unit in an inpatient bed with vital sign monitoring per institutional transfusion protocol. Post-transfusion hemoglobin and clinical response are documented; any transfusion reaction signs trigger immediate transfusion stop, transfusion reaction workup, and notification of the transfusion service and attending physician.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | When no modifier applies to the billing claim for this supply |